Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 50.20
-1.50 (-2.90%)
Apr 29, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 41.68 billion as of April 29, 2026. Its market cap has increased by 681.04% in one year.
Market Cap
41.68B
Enterprise Value
41.41B
Revenue
1.78B
Ranking
n/a
PE Ratio
61.65
Stock Price
50.20
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 41.68B, an increase of 304.07%. That is a compound annual growth rate of 46.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 41.68B | 76.71% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 44.97B |
| Shanghai Junshi Biosciences | 41.69B |
| 3SBio | 56.85B |
| Genscript Biotech | 30.30B |
| InnoCare Pharma | 29.74B |
| RemeGen | 75.51B |
| Duality Biotherapeutics | 26.43B |
| Shanghai Bao Pharmaceuticals | 25.38B |